Skip to main content
. 2017 Mar 21;8(38):62858–62867. doi: 10.18632/oncotarget.16399

Table 2. Comparison of survival fraction (%) between two groups.

Groups 0 h 24 h 48 h 72 h
CNE2R-CD166(+) 100 81.16 ± 2.84 74.64 ± 1.66 65.83 ± 2.41
CNE2R-CD166(−) 100 67.24 ± 2.83 53.60 ± 4.19 46.68 ± 2.63
P 0.004 0.001 0.001